v3.26.1
Basis of presentation
6 Months Ended
Jun. 30, 2026
Basis of presentation [Abstract]  
Basis of presentation
2.Basis of presentation

 

[a] Statement of compliance

 

These condensed consolidated interim financial statements (“financial statements’) were prepared using the same accounting policies and methods as those used in the Company’s audited consolidated financial statements for the year ended December 31, 2025. These financial statements have been prepared in compliance with IAS 34 – Interim Financial Reporting. Accordingly, certain disclosures normally included in annual financial statements prepared in accordance with IFRS® Accounting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) have been omitted or condensed. These financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2025.

 

These financial statements were approved and authorized for issuance by the Board of Directors (the “Board”) of the Company on August 13, 2026.

 

[b] Functional currency and presentation currency

 

The financial statements of each company within the consolidated group are measured using their functional currency, which is the currency of the primary economic environment in which an entity operates. These condensed consolidated interim financial statements are presented in United States dollars ("USD"), which is the Company’s functional and presentation currency for all years presented. The Company’s functional currency is the United States dollar, and the functional currencies of its subsidiaries are as follows:

  

FSD Biosciences Inc. United States Dollar
Prismic Pharmaceuticals Inc. United States Dollar
FV Pharma Inc. Canadian Dollar
Lucid Psycheceuticals Inc. Canadian Dollar
FSD Strategic Investments Inc. Canadian Dollar
FSD Pharma Australia Pty Ltd Australian Dollar
Unbuzzd Wellness Inc. Canadian Dollar
Huge Biopharma Australia Pty Ltd Australian Dollar

[c] Use of estimates and judgments

 

The preparation of these financial statements in conformity with IFRS requires management to make estimates, judgements and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, consistent with those disclosed in the audited consolidated financial statements for the year ended December 31, 2025, and described in these financial statements. Actual results could differ from these estimates.

 

Estimates are based on management’s best knowledge of current events and actions that the Company may undertake in the future. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

 

[d] Comparative figures

 

Certain amounts in the prior year have been reclassified to conform with classification in the current year.